March 13, 2015 Dr. Reinilde Heyrman Subject: Amendment to Employment Agreement Dear Reinilde:Employment Agreement • May 15th, 2015 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations
As we verbally discussed, this letter represents an amendment (the “Amendment”) to the Employment Agreement, dated as of March 26, 2012, between you and Ikaria, Inc. (“Ikaria”), which Employment Agreement was assumed by Bellerophon Therapeutics, Inc. (“Bellerophon”) in connection with Bellerophon’s spin-out from Ikaria in February 2014 (the “Employment Agreement”).
March 13, 2015 Mr. Jonathan Peacock Subject: Amendment to Employment Agreement Dear Jon:Employment Agreement • May 15th, 2015 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations
This letter represents an amendment (the “Amendment”) to the Employment Agreement, dated as of June 20, 2014, between you and Bellerophon Therapeutics, Inc. (the “Employment Agreement”).
March 13, 2015 Dr. Martin Meglasson Subject: Amendment to Employment Agreement Dear Martin:Employment Agreement • May 15th, 2015 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations
As we verbally discussed, this letter represents an amendment (the “Amendment”) to the Employment Agreement, dated as of August 10, 2010, between you and Ikaria, Inc. (“Ikaria”), which Employment Agreement was assumed by Bellerophon Therapeutics, Inc. (“Bellerophon”) in connection with Bellerophon’s spin-out from Ikaria in February 2014 (the “Employment Agreement”).
March 13, 2015 Mr. Manesh Naidu Subject: Amendment to Employment Agreement Dear Manesh:Employment Agreement • May 15th, 2015 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations
As we verbally discussed, this letter represents an amendment (the “Amendment”) to the Employment Agreement, dated as of January 4, 2012, between you and Ikaria, Inc. (“Ikaria”), which Employment Agreement was assumed by Bellerophon Therapeutics, Inc. (“Bellerophon”) in connection with Bellerophon’s spin-out from Ikaria in February 2014 (the “Employment Agreement”).
